Trained immunity across organs

Paula Jauregui

DOI: https://doi.org/10.1038/s41590-024-01958-y

IF: 30.5

2024-08-31

Nature Immunology

Abstract:Acute brain injuries due to ischemic stroke can develop in long-term secondary comorbidities. In Cell , Simats et al. find that trained immunity after stroke drives inflammatory cardiac dysfunction. Using single-cell RNA sequencing (scRNA-seq) in a mouse model of experimental ischemic stroke and myocardial autopsy samples from stroke patients, they find marked cardiac fibrosis with increased recruitment of pro-inflammatory cardiac monocytes and macrophages. In addition, the authors find chronic alteration of the bone marrow (BM) myeloid compartment after stroke. In a genetic model of BM depletion, enriched hematopoietic stem and progenitor cells (HSPCs) from BM 1 month after stroke were transplanted into naive recipients, and scRNA-seq analysis indicated that myeloid function is altered and drives secondary cardiac fibrosis. To determine whether transcription factors were involved in epigenetic reprograming of myeloid cells, the authors performed single-cell assay for transposase-accessible chromatin with sequencing (ATAC-seq) and found that secretion of IL-1β after stroke induces epigenetic changes that lead to trained immunity. The authors treated mice with IL-1β or IL-1β-neutralizing antibodies and found that the IL-1β-driven trained immunity can mediate chronic cardiac fibrosis after stroke. Blocking the migration of pro-inflammatory myeloid cells to secondary organs using the dual C-C chemokine receptors type 2 and 5 antagonist cenicriviroc (CVC) prevented cardiac dysfunction after stroke. In summary, the findings that innate immune memory and chronic changes in resident innate immune cells across several organs contribute to cardiac dysfunction demonstrate the potential for new treatments to prevent cardiac comorbidities after stroke. Original reference: Cell https://doi.org/10.1016/j.cell.2024.06.028 (2024)

immunology